Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leishmania intracellular amastigotes are the non-motile, spherical life cycle stage of the Leishmania protozoan parasite that resides within the phagolysosomes of mammalian host macrophages (World Health Organization, 2023). This stage is responsible for the clinical manifestations}
Drugs targeting this stage act through various mechanisms including disruption of the parasite cell membrane (Amphotericin B), inhibition of protein synthesis (Paromomycin), interference with thiol metabolism and DNA topoisomerase (Antimonials), and induction of apoptosis-like cell death (Miltefosine).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leishmania intracellular amastigote.